EP
PerMed News |
|
13 October 2026 Pre-announcement:
EP PerMed JTC2027
EP
PerMed is launching the Joint Transnational Call
2027 for Cell and Gene Therapy for Personalised Medicine
(CGT4PM2027). The call aims to fund projects
focusing on the development and validation of innovative
and novel cell and gene therapies for personalised
medicine. The full call text will be published on 4
November 2026.
Read
more |
|
17
September 2026
New
EP PerMed Report Explores Public Awareness and
Perceptions of Personalised Medicine
EP
PerMed has published a new report presenting the first
results of its multilingual survey on public awareness,
perceptions, expectations and concerns regarding
Personalised Medicine (PM). The findings provide a
baseline for understanding how people perceive
personalised medicine and highlight important priorities
for communication, engagement, trust and equitable
access.
Read more |
|
08 September 2026
Join
the EP PerMed Stakeholder Forum to Move Personalised
Medicine Forward
The
EP PerMed Stakeholder Forum brings together researchers,
clinicians, companies, patients, regulatory
stakeholders, and other key players in personalised
medicine (PM) on a single platform to accelerate the
translation of research findings into clinical practice
and marketable applications.
Read more |
|
27
- 29 April 2027
Joint
EP PerMed & ICPerMed Conference in Berlin
EP
PerMed and ICPerMed will jointly organise a conference
in Berlin, Germany, from 27 to 29 April 2027. The event
will focus on collaborations to accelerate personalised
medicine innovations and solutions into healthcare.
Networking and exchange between research, innovation and
healthcare are at the heart of the conference, which
brings together the personalised medicine community from
Europe and beyond.
Read more |
|
23 July 2026
Round
Table Report Highlights Pathways to Implement
Personalised Medicine in Nordic Countries
EP
PerMed has published the summary report of its third
round table, which examined challenges, successful
approaches and industry perspectives on the
implementation of personalised medicine in the Nordic
countries. The round table took place on 18 May 2026 in
Copenhagen, Denmark, bringing together representatives
from companies, healthcare innovation organisations,
public funding bodies and national personalised medicine
infrastructures.
Read more |
Other
PM-related News |
|
12 October
2026
JA
PCM Invites Stakeholders to Shape a Public-Private
Partnership for Personalised Cancer Medicine
The
Joint Action on Personalised Cancer Medicine (JA PCM) is
inviting patients, citizens and public stakeholders to
two online consultations on 26 and 27 October 2026. The
discussions will contribute to the development of a
possible public-private partnership (PPP) for
personalised cancer medicine that could continue beyond
the Joint Action.
Read more |
|
16
September 2026
New
Regional Funding Opportunities for Digital Health
Two
new funding opportunities of interest to the
personalised medicine community have recently been
launched or announced through the UNITE and SYSTEMEU
initiatives. The calls support the development and
implementation of digital health solutions across
Europe.
Read more |
|
14 September
2026
Health-NCP-Net
3.0 Publishes Guide to Health Funding Opportunities
Across Horizon Europe
Health-NCP-Net
3.0 (HNN 3.0) has published ‘Health research and
innovation funding opportunities across Horizon Europe
with deadlines from September to December 2026’. The
guide brings together health-related opportunities from
the 2026-2027 Horizon Europe Work Programmes across all
three pillars, extending beyond Cluster 1: Health.
Read more |
|
See all news |
Events |
|
21 October
2026 - Cyber Resilient Healthcare
27 October
2026 - ERA4Health Synergies Workshop 2026:
Bridging Knowledge and Action: Advancing Policy Uptake
through Synergies
26 October
2026 - Towards a Public-Private-Partnership in
Personalised Cancer Medicine: Patients' and Citizens'
Perspective
27 October
2026 - Towards a Public-Private-Partnership in
Personalised Cancer Medicine: Public Stakeholders'
Perspective |
|
27
- 30 October 2026 - EP PerMed Implementation School on
Personalised Medicine - A Sex- and Gender-Sensitive
Approach |
|
02
- 03 November 2026 - Network Meeting on Brain Tumours
16 November
2026 - TEHDAS2 Final Conference
24
- 25 November 2026 - HNN3.0 | Brokerage Event on Horizon Europe
Cluster 1 2027 Calls
26 November
2026 - Horizon Europe Info Days - Cluster
1 |
|
03 December
2026 - EP PerMed JTC2027 Information
Day |
|
04 December
2026 - 1+ Million Genomes Initiative – High-level
Event
18
- 21 January 2027 - PRISM Networking Event: Digital Twins for
Personalised Radiotherapy through Integrated Simulation
and Modelling |
|
27
- 29 April 2027 - Joint EP PerMed & ICPerMed Conference
in Berlin |
|
See all events
|